Download presentation
1
Pathophysiology of Urinary Tract Obstruction
Jamie Bartley D.O. PGY 3..almost 4 5/27/09 MSU-COM Metro Detroit Urology
2
Outline I. Background II. Pathophysiology and pathological changes with urinary tract obstruction III. Patient work-up and management IV. Causes of urinary tract obstruction
3
Definitions Hydronephrosis- Dilation of the renal pelvis or calyces
Obstructive uropathy- functional or anatomic obstruction of urine flow at any level of the urinary tract Obstructive nephropathy- when obstruction causes function or anatomic renal damage
4
Prevalence 3.1% in autopsy series No gender differences until 20 years
Females more common 20-60 Males more common older than 60 2-2.5% of children at autopsy
5
Causes of Obstructive Nephropathy
Table 37-1 -- Possible Causes of Obstructive Nephropathy Renal- Congenital, Polycystic kidney, Renal cyst, Fibrous obstruction at ureteropelvic junction, Peripelvic cyst, Aberrant vessel at ureteropelvic junction Neoplastic- Wilms' tumor, Renal cell carcinoma, Transitional cell carcinoma of the renal pelvis, Multiple myeloma Inflammatory- Tuberculosis, Echinococcus Infection Metabolic- Calculi Miscellaneous- Sloughed papillae, Trauma, Renal artery aneurysm Ureter Congenital- Stricture, Ureterocele, Ureterovesical reflux, Ureteral valve, Ectopic kidney, Retrocaval ureter, Prune-belly syndrome Neoplastic- Primary carcinoma of ureter, Metastatic carcinoma Inflammatory- Tuberculosis, Schistosomiasis, Abscess, Ureteritis cystica, Endometriosis Miscellaneous- Retroperitoneal fibrosis, Pelvic lipomatosis, Aortic aneurysm, Radiation therapy, Lymphocele, Trauma, Urinoma, Pregnancy Bladder and Urethra Congenital- Posterior urethral valve, Phimosis, Urethral stricture, Hypospadias and epispadias, Hydrocolpos Neoplastic- Bladder carcinoma, Prostate carcinoma, Carcinoma of urethra, Carcinoma of penis Inflammatory- Prostatitis, Paraurethral abscess Miscellaneous-Benign prostatic hypertrophy, Neurogenic bladder
6
Global Renal Functional Changes
Obstruction can affect hemodynamic variables and GFR Degree of affect depends on extent and severity of obstruction, whether UUO or BUO, and whether it has been relieved or not GFR= Kf(PGC-PT-PGC) Need to understand in order to comprehend the relationships between changes in renal hemodynamics and alterations in GFR during and after obstruction RPF= (aortic pressure-renal venous pressure) renal vascular resistance Influences PGC Constriction of the afferent arteriole will result in a decrease of PGC and GFR An increase in efferent arteriolar resistance will increase PGC Kf- flomerular ultrafiltration coeffecient related to the surface area and permeability of the capillary membrane PGC- glomerular capillary pressure. Influenced by renal plasma flow and the resistance of the afferent and efferent arterioles PT- Hydraulic pressure of fluid in the tubule P- the oncotic pressure of the proteins in the glomerular capillary and efferent arteriolar blood
7
Hemodynamic Changes with Unilateral Ureteral Occlusion
Triphasic pattern of renal blood flow and ureteral pressure changes 1. RBF increases during the first 1-2 hours and is accompanied by a high PT and collecting system pressure 2. For another 3-4 hours, the pressures remains elevated but the RBF begins to decline 3. 5 hours after obstruction, further decline in RBF occurs. A decrease in PT and collecting system pressure also occurs
8
Triphasic pattern of UUO
9
Hemodynamic Changes with Unilateral Ureteral Occlusion
Alterations in flow dynamics within the kidney occur dye to changes in the biochemical and hormonal milieu regulating renal resistance Phase I- The increased PT is counterbalanced by an increase in renal blood flow via net renal vasodilation, which limits the fall of GFR PGE2, NO – Contribute to net renal vasodilation early in UUO Phase II and III- An increase in afferent arteriolar resistance occurs causing a decrease RPF. A shift in RBF from the outer cortex to the inner cortex also occurs all reducing GFR Angiotensin II, TXA2, Endothelin - mediators of the preglomerular vasoconstriction during the 2nd and 3rd phase of UUO
10
Hemodynamic Changes with Bilateral Ureteral Occlusion
Only a modest increase in RBF lasting 90 minutes followed by a prolonged and profound decrease in RBF that is even more than with UUO The intrarenal distribution of blood flow changes from the inner to the outer cortex (opposite from UUO) Accumulation of vasoactive substances (ANP) in BUO that contributes to preglomerular vasodilation and postglomerular vasoconstriction With UUO, these substances would be excreted by the normal kidney When obstruction is released, GFR and RBF remain depressed due to persisent vasoconstriction of the afferent arteriole The post-obstructive diuresis is much greater than with UUO
11
Summary of UUO and BUO
12
Partial Ureteral Occlusion
Changes in renal hemodynamics and tubular function are similar to complete models of obstruction Develop more slowly Animal Studies- Difficult to imitate partial obstruction 14 days- normal functional recovery 28 days- recover 31% of function 60 days- recovery 8% of function
13
Effects of Obstruction on Tubular Function
Dysregulation of aquaporin water channels in the proximal tubule, thin descending loop, and collecting tubule Lead to polyuria and impaired concentrating capacity Sodium Transport Decreased which leads to a role in the postobstructed kidney’s impaired ability to concentrate and dilute urine Much greater sodium and water excretion after release of BUO than UUO Thought to be due to the retention of Na, water, urea nitrogen and increased ANP, all which stimulate a profound naturesis Potassium and phosphate excretions follow changes in sodium Decreased with UUO Increased transiently with BUO in parallel with the massive diuresis Deficit in urinary acidification Magnesium excretion is increased after release of UUO or BUO Changes in pepetide excretion mark renal damage
14
Cellular and Molecular Changes lead to Fiborosis and Tubular Cell Death
Obstruction leads to biochemical, immunologic, hemodynamic, and functional changes of the kidney A cascade of events occur which lead to release of angiotensin II, cytokines, and growth factors (TGF-B, TNF-a, NFkB) Some mediators are produced directly from the renal tubular and interstitial cells Others are generated by way of fibroblasts and macrophages Progressive and permanent changes to the kidney occur Tubulointerstitial fibrosis Tubular atrophy and apoptosis Interstitial inflammation
15
Pathologic Changes of Obstruction (porcine model)
Gross Pathologic Changes 42 hours- Dilation of the pelvis and ureter and blunting of the papillary tips. Kidney also heavier 7days- Increased pelviureteric dilation and weight. Parenchyma is edematous 21-28 days- External dimensions of kidneys are similar but the cortex and medullary tissue is diffusely thinned 6 weeks- Enlarged,cystic appearing, weighs less than non-obstructed kidney Did not see such differences in partially obstructed kidneys
16
Pathologic Changes of Obstruction (porcine model)
Microscopic Pathologic Findings 42 hours- Lymphatic dilation, interstitial edema, tubular and glomerular preservation 7 days- Collecting duct and tubular dilation, widening of Bowman’s space, tubular basement membrane thickening, cell flattening 12 days- Papillary tip necrosis, regional tubular destruction, inflammatory cell response 5-6 weeks- widespread glomeular collapse and tubular atrophy, interstitial fibrosis, proliferation of connective tissue in the collecting system
17
Compensatory Renal Growth
Enlargement of the contralateral kidney with unilateral hydronephrosis or renal agenesis A reduction in compensatory growth occurs with age An increase in the number of nephrons or glomeruli does not occur, despite enlargement
18
Renal Recovery after Obstruction
Degree of obstruction, age of patient, and baseline renal function affect chance of recovery Two phases of recovery may occur Tubular function recovery GFR recovery Duration has a significant influence Full recovery of GFR seen with relief of acute complete obstruction Longer periods of complete obstruction are associated with diminished return of GFR DMSA scan is predicative of renal recovery
19
Now on to the Clinical Stuff…
20
Management of Patients with Obstruction Diagnostic Imaging
Renal US Safe in pregnant and pediatric patients Good initial screening test No need for IV contrast May have false negative in acute obstruction (35%) Hydronephrosis= anatomic diagnosis Can have caliectasis or pelviectasis in an unobstructed system Doppler- measures renal resistive index (RI), an assessment of obstruction RI= (PSV-EDV)/PSV RI > 0.7 is suggestive elevated resistance to blood flow suggesting obstructive uropathy
21
Diagnostic Imaging Excretory Urography
Applies anatomic and functional information Limited use in patients with renal insufficiency Increased risk of contrast-induced nephropathy Cannot use in patients with contrast allergy
22
Diagnostic Imaging Retrograde Pyelography Antegrade Pyelography
Gives accurate details of ureteral and collecting system anatomy Good if renal insufficiency or other risks for contrast Loopogram- use for evaluation of patients with cutaneous diversions Antegrade Pyelography Can do if RGP is not possible and other imaging doesn’t offer enough details
23
Diagnostic Imaging Whitaker Test
“True pressure” within the pelvis = Collecting system pressure – intravesicle presure Saline or contrast though a percutaneous needle or nephrostomy tube at a rate of 10mL/ min Catheter in bladder to monitor intravesicle pressure Invasiveness and discordant results limit clinical usefulness Normal < 15 cm H2O Indeterminate = cm H2O Obstruction > 22 cm H2O
24
Diagnostic Imaging Nuclear Renography
Provides functional assessment without contrast Obstruction is measured by the clearance curves Tc 99m DTPA- glomerular agent Tc 99m MAG3 – tubular agent Diuretic renogram- maximizes flow and distinguishes true obstruction from dilated and unobstructed Normal = T ½ < 10 min Indeterminate = T ½ min Obstructed T ½ > 20 min
25
Diagnostic Imaging MRI CT
Can identify hydro but unable to identify calculi and ureteral anatomy of unobstructed systems Diuretic MRU can demonstrate obstruction Especially accurate with strictures or congential abnormalities IV gadopentetate-DTPA allows functional assessment of collecting system while providing anatomic detail GFR assessment Renal clearance Still several limitations in its use CT Most accurate study to diagnose ureteral calculi More sensitive to identify cause of obstruction Helpul in surgical planning **Preferred initial imaging study in those with suspected ureteral obstruction
26
Issues in Patient Management
Hypertension Can be caused by ureteral obstruction Especially BUO or obstruction of a solitary kidney Less common with UUO Volume-mediated Increased ANP with obstruction which normalizes after drainage Decreased plasma renin activity
27
Issues in Patient Management
Renal Drainage Endourologic or IR procedures allow prompt temporary and occasionally permanent drainage No statistically significant difference in HRQL between the two techniques Patients with extrinsic compression causing obstruction have a high risk of ureteral stent failure % failure rate at 3 months 43% failed within 6 days of placement in one study High failure rate at even getting placement(27%) Stent diameter did not predict risk of failure Ultrasound guided percutaneous drainage should be initial consideration in pregnant patients Percutaneous placement with suspected pyonephrosis Large diameter ureteral stents
28
Issues in Patient Management Considerations in Surgical Intervention
Reconstruction Endoscopic, open and laparoscopic techniques should be considered Need for nephrectomy? Allow 6-8 weeks for adequate drainage before proceeding Nuclear imaging provides accurate functional information < 10% contribution to global renal function is considered threshold for nephrectomy
29
Issues in Patient Management Pain
Increases in collecting system pressure and ureteral wall tension contribute to renal colic Results in spinothalamic C-fiber excitation Treating Pain Narcotics Rapid onset, nausea, sedation, abuse NSAIDS Targets the inflammatory basis of pain by inhibiting prostaglandin synthesis Reduces collecting system pressure by decreasing renal blood flow Avoid in patients with renal insufficiency, GI bleeds
30
Issues in Patient Management Postobstructive Diuresis
Usually with BUO or solitary kidney Urine output > 200ml/hour A normal physiologic response to volume expansion and solute accumulation Elimination of sodium, urea, and free water Diuresis ends when homeostasis returns Pathologic postobstructive diuresis Impaired concentating abilility or sodium absorption Downregulation of sodium transporters and sodium reabsorption in the thick ascending loop of Henle Increased production and altered regulation of ANP Poor response of collecting system to ADH
31
Issues in Patient Management Postobstructive Diuresis
Monitor those with BUO or UUO in solitary kidney for POD Electrolytes, Mg, BUN, Cr Intensity of monitoring depends on clinical factors If no signs of POD If alert, no fluid overload, normal renal function, normal lytes, discharge and follow up If signs of POD If alert, able to consume fluids, normal VS continue in-patient observation, free access to oral fluids, and daily labs until diuresis resolves (No IV Fluids) If signs of POD and signs of fluid overload, poor renal function, hypovolemia, or MS changes Frequent VS and u.o records, labs q 12 hrs (or more), urinary osmolarity, restrict oral hydration (Minimal IV fluid hydration) Most have self-limiting physiologic diuresis If pathologic diuresis occurs- very intense monitoring is indicated
32
Selected Causes of Extrinsic Ureteral Obstruction
33
Retroperitonal Fibrosis
Condition in which an inflammatory mass, a fibrous whitish plaque, envelops and potentially obstructs retroperitoneal structures Usually extends from the renal hilum to pelvic brim May involve the mediastinum and the pelvis 2 phases lead to its development 1. Autoimmune reaction thought to occur due to leakage of ceroid from the atheromatous plaques in the aorta Local inflammatory reaction characterized by plasma cells, lymphocytes, macrophages, eosinophils 2. Fibrotic maturation with development of homogeneous fibrous tissue with limited cellularity
34
Retroperitoneal Fibrosis
1: 200,000, 3:1 Male: Female, Age 50 2/3s of Cases are “Idiopathic” 8-10% of cases have underlying malignancy Other causes: Medications (methysergide, hydralazine, Haldol, B-Blockers, LSD, Phenacetin, Amphetamines), RP hemorrhage, urinary extravasation, trauma, radiation, IBD, Gonorrhea, collagen disease, peri-aneurysmal inflammation Symptoms- Dull, non-colicky pain in a “girdle” distribution, ureteral or vascular obstruction (late)
35
Retroperitoneal Fibrosis
Diagnosis IVP- Medial deviation of the ureters Can be seen in 18% of normal subjects CT – well demarcated mass that is isodense with muscle (non-contrast study) MRI- Allows superior soft tissue discrimination and can more accurately distinguish the plaque from the great vessels
36
Diagnosis of Retroperiteoneal Fibrosis
37
Retroperitoneal Fibrosis
Treatment 1. Correct obstructive uropathy 2. Biopsy to exclude malignancy 3. If biopsy is negative, medical therapy is preferred Discontinue any offending medications Corticosteroids- prednisolone 60mg qod x 2 mos, tapered to 5mg daily over the next 2 months, then continue 5mg daily for 2 years Tamoxifen Immunotherapy 4. Ureterolysis- if patient not a candidate for medical therapy or if it fails - May do open or laparoscopic - Bilateral treatment is recommended even if unilateral disease - To prevent recurrent ureteral involvement bring ureter intraperitoneal, or wrap in omentum - Stents can usually be removed 6-8 wks after ureterolysis Experimental
38
Pelvic Lipomatosis Rare benign proliferative disease involving the mature fatty tissues of the pelvic retroperitoneum 18:1 Male to female More common in African American men Unknown etiology Obesity? Genetic?
39
Pelvic Lipomatosis Patient Presentation and Diagnosis
LUTS, Constipation, non-specific pain, HTN Physical Exam- suprapubic mass, high riding prostate, indistinct pelvic mass Younger patients are thought to have a more progressive course than older patients who have a more indolent course
40
Pelvic Lipomatosis Imaging KUB- Pelvic lucency
IVP- Bladder is pear-shaped and elevated, hydronephrosis may be evident CT- pelvic fat is readily demonstrated
41
Pelvic Lipomatosis Other evaluation Treatment
Cystoscopy- cystitis cystica, cystitis glandular (40%), adenocarcinoma, chronic UTI High bladder neck, pelvic fixation, and elongated prostatic urethra may impair rigid cystoscopy Treatment Exploration is not recommended due to the obliteration of normal planes and increased vascularity of the mass In patients with obstructive uropathy stents, PCNs, ureteral reimplanation, urinary diversion
42
Pregnancy Reported to occur in 43-100% Right > Left Etiology
Hormonal- progesterone thought to promote ureteral dilation Mechanical – increased degree of dilation after 20 weeks when the uterus reaches the pelvic brim
43
Pregnancy Diagnosis Treatment Usually asymptomatic
If symptoms, may have flank pain or pyelonephritis US will show dilation to the pelvic brim If it extends below this, consider other etiologies (stone) Limited IVU or MRI to diagnose Treatment Most respond to conservative treatment IVF, analgesics, antibiotics If signs of sepsis or compromised renal function may need ureteral stents or nephrostomy tubes
44
Endometriosis GU involvement Bladder 70-80% Ureter 15-20%
May be intrinsic or extrinsic (80%) Cyclical flank pain, dysuria, urgency, UTI, hematuria, or no GU symptoms (silent loss of renal function may occur) Recommended to image the Upper tracts in all patients with pelvic endometriosis (RUS or EXU)
45
Endometriosis Treatment
Hormone therapy- if normal renal function with mild hydro and no functional obstruction seen on renogram GnRH agonists Surgery- treatment of choice for patients with significant disease TAH with BSO Unilateral oopherectomy Ureterolysis if extrinsic disease Distal ureterectomy with reimplantation
46
Vascular Causes of Ureteral Obstruction
Abdominal Aortic Aneurysm Ureteral obstruction may be the first sign Medial deviation of the ureters associated with the desmoplastic reaction of inflammatory AAA (IAAA) more likely to cause obstruction than lateral deviation Stent placement usually recommended prior to aneurysmal repair Ureterolysis usually not needed and obstruction resolves with correction of the aneurysm
47
Circumcaval Ureter Anomalous course of the ureter to the IVC leading to extrinsic obstruction Thought to be due to the persistence of the subcardinal vein as the infrarenal IVC, causing medial migration and compression of the right ureter Other theories involve persistence of the posterior cardinal vein as the infrarenal cava Both, theories note failure of the supracardinal vein to develop into the infrarenal IVC
48
Circumcaval Ureter
49
Circumcaval Ureter Treatment is performed only in presence of obstruction Divide ureter proximally and at the distal point it emerges lateral to the IVC Spatulated ureterostomy performed
50
Other causes of vascular obstruction
Iliac Artery Aneurysm Typically place internal ureteral stents prior to aneurysmal repair Obstruction after Vascular Graft placement Usually resolves spontaneously Graft transection and repositioning Chronic stenting Puerperal Ovarian Vein Thrombophlebitis Antiobiotic therapy usually resolves
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.